三生制药:暴涨 40% 获辉瑞巨额合作 12.5 亿

和讯网
20 May

【三生制药早盘股价飙升,一度暴涨 40%】截至发稿,三生制药股价上涨 36.28%,现报 19.76 港元,成交额 31.93 亿港元,高见 22 港元,逼近历史前高 22.63 港元。三生制药公告,其与辉瑞公司就自主研发的 PD-1/VEGF 双特异性抗体 SSGJ-707 签订独家许可协议。辉瑞获全球开发、生产和商业化独家权利,三生制药将获 12.5 亿美元首付款,最高可达 48 亿美元的开发...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10